BIOVIE INC. (BIVI)
2025-06-30 | ||||
|---|---|---|---|---|
| Reclassification of unrealized gains on available-for-sale investments upon settlement | - | |||
| Total other comprehensive loss | - | |||
| Selling, general and administrative expenses | 8,570,089 | |||
| Research and development expenses | 9,266,734 | |||
| Amortization of intangible assets | 229,377 | |||
| Total operating expenses | 18,066,200 | |||
| Loss from operations | -18,066,200 | |||
| Interest income | 853,029 | |||
| Interest expense | 332,720 | |||
| Change in fair value of derivative liabilities | 3,771 | |||
| Total other income , net | 524,080 | |||
| Net loss | -17,542,120 | |||
| Deemed dividend related to ratchet adjustment to warrants | 369,465 | |||
| Net loss attributable to common stockholders | -17,911,585 | |||
| Comprehensive loss | -17,911,585 | |||
| - basic | -12.12 | |||
| - basic | 1,477,372 | |||
| - diluted | -12.12 | |||
| - diluted | 1,477,372 | |||